Valuation: Gujarat Terce Laboratories Limited

Market Cap 303M 3.2M 2.86M 2.66M 2.42M 4.54M 4.63M 31.9M 12.48M 158M 12.01M 11.76M 506M P/E 2025
-46.3x
P/E 2026 10.6x
Enterprise Value 274M 2.89M 2.58M 2.4M 2.18M 4.11M 4.18M 28.83M 11.28M 143M 10.86M 10.63M 458M EV / Sales 2025
0.9x
EV / Sales 2026 0.45x
Free-Float
55.32%
Yield 2025 *
-
Yield 2026 -
1 day-3.90%
1 week+9.14%
Current month+7.81%
1 month-5.10%
3 months+17.27%
6 months+17.16%
Current year-10.55%
1 week 36
Extreme 36
43
1 month 34.51
Extreme 34.51
43
Current year 29
Extreme 29
50
1 year 29
Extreme 29
56.49
3 years 19.62
Extreme 19.62
94.9
5 years 12.78
Extreme 12.78
94.9
10 years 5.71
Extreme 5.71
94.9
Manager TitleAgeSince
Chief Executive Officer 38 28/10/2021
Director of Finance/CFO 49 17/12/2018
Compliance Officer 30 13/02/2020
Director TitleAgeSince
Chairman 74 27/11/2012
Director/Board Member 48 27/06/2017
Director/Board Member 38 01/04/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.90%+9.14%-27.47%+57.34% 3.32M
+3.55%+7.01%+51.42%+105.45% 1,077B
-0.25%-1.25%+32.49%+61.48% 612B
+0.59%+4.03%+25.28%+91.54% 501B
-1.48%+1.97%+72.62%+39.59% 364B
+2.37%+7.66%+33.65%+48.87% 353B
+2.64%+6.95%+21.01%+43.85% 278B
+3.24%+6.78%+0.43%+15.71% 251B
+1.86%+6.53%+45.98%+52.77% 230B
+2.49%+6.98%+33.03%+102.67% 190B
Average +1.11%+4.51%+28.84%+61.93% 385.65B
Weighted average by Cap. +1.74%+4.12%+38.65%+71.72%

Financials

2025 2026
Net sales 502M 5.3M 4.73M 4.4M 4M 7.52M 7.66M 52.81M 20.66M 262M 19.89M 19.47M 838M 475M 5.01M 4.47M 4.16M 3.78M 7.12M 7.24M 49.95M 19.54M 248M 18.81M 18.41M 793M
Net income -9.79M -103K -92.23K -85.72K -77.97K -147K -149K -1.03M -403K -5.11M -388K -380K -16.34M 22.02M 232K 207K 193K 175K 330K 336K 2.32M 906K 11.49M 872K 854K 36.76M
Net Debt -3.49M -36.85K -32.89K -30.57K -27.81K -52.31K -53.26K -367K -144K -1.82M -138K -135K -5.83M -29.11M -307K -274K -255K -232K -436K -444K -3.06M -1.2M -15.19M -1.15M -1.13M -48.61M
Projected Income Statement - Annual - Gujarat Terce Laboratories Limited
Logo Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its product basket includes branded as well as generic formulations offering solutions for disease prevention and control. It offers a range of products under 52 brands, totaling 135 items approximately, and its portfolio covers 10 therapeutic categories such as respiratory, gynecology, antibiotics, pain therapy, gastrology, nutraceutical, and ayurvedic therapies. The Company’s brands include Acolate, Codimol, Terflora Z, Thyter, Tynol, Moxxil and Vitfol, among others. It caters to both domestic and international markets. The manufacturing facility of the Company is located at Chhatral in Gandhinagar, Gujarat.
Employees
234
Date Price Change Volume
15/10/26 ₹38.91 -3.90% 2,109
14/10/26 ₹40.49 -0.83% 137
13/10/26 ₹40.83 -1.71% 1,362
12/10/26 ₹41.54 +14.75% 10,687
09/10/26 ₹36.20 +1.54% 649
  1. Stock Market
  2. Stocks
  3. 524314 Stock